Jennifer L. Good, President & CEO at Trevi Therapeutics, Inc. (TRVI), sold 4,578 shares at $2.90 ($13K) on 2024-05-10, disclosed to the SEC on 2024-05-14.
Open-market sale of $13k TRVI by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RYTM | SELL | 2024-09-11 | $3.8M | — | Filing → |
| TRVI | SELL | 2024-09-09 | $18K | — | Filing → |
| TRVI | SELL | 2024-09-05 | $295K | — | Filing → |